Back to search
FDAFDA · Food and drugs·Recall number D-1575-2014

PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5

Published September 10, 2014 · Recall initiated: March 24, 2014

Summary

FDA records drug Class II recall D-1575-2014, published September 10, 2014 and initiated March 24, 2014. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 13,429 bottles; Lot: Lot # 2A001, Exp. 01/15; Lot # 2C002, Exp. 03/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot # 2A001, Exp. 01/15; Lot # 2C002, Exp. 03/15
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5 recalled?

Yes. FDA published recall D-1575-2014 on September 10, 2014. Reported hazard: Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

What should I do if I have this product?

Voluntary: Firm initiated · Letter